4 Results for "

2-MeS-ADP

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "2-MeS-ADP" in MCE Product Catalog:

Cat. No.: HY-108648
CAS No.: 475193-31-8
Purity:  99.90%
Synonyms: 2-Methylthioadenosine diphosphate trisodium; 2-Methylthio-ADP trisodium
Target:  

P2Y Receptor

Research Areas:  

Neurological Disease

2-Methylthioadenosine diphosphate trisodium is a potent purinergic P2Y receptors agonist, with EC50s of 19, 6.2, and 5 nM for human P2Y13, mouse P2Y13 and human P2Y12, respectively. 2-Methylthioadenosine diphosphate trisodium has pEC50s of 8.29 and 5.75 for human P2Y1 and rat P2Y6, respectively. 2-Methylthioadenosine diphosphate trisodium induces platelet aggregation and shape change, and inhibits cyclic AMP accumulation in platelets exposed to prostaglandin E1 [2] .
loading...
    loading...
Cat. No.: HY-108648A
CAS No.: 34983-48-7
Synonyms: 2-Methylthioadenosine diphosphate; 2-Methylthio-ADP
Target:  

P2Y Receptor

Research Areas:  

Neurological Disease

2-MeSADP is a P2Y receptor agonist, with an EC50 of 5 nM for human P2Y12, EC50 values of 19 nM and 13 nM for human P2Y13, and an EC50 of 6.2 nM for mouse P2Y13. It shows slightly higher selectivity for P2Y12 over human P2Y13. 2-MeSADP triggers increases in intracellular calcium levels, Gi-mediated cAMP inhibition, adenylate cyclase inhibition and downstream signal transduction. 2-MeSADP can be used in research related to glaucoma [2] .
loading...
    loading...
Cat. No.: HY-123669
CAS No.: 204204-73-9
Research Areas:  

Cardiovascular Disease

R-138727, the major active metabolite of Prasugrel (HY-15284), is a highly potent and selective irreversible antagonist of the P2Y12 receptor, with an IC50 of 2.5 μM. R-138727 covalently binds to the P2Y12 receptor on the platelet surface, blocking adenosine diphosphate-mediated platelet activation and aggregation. R-138727 can be used to study stroke, cerebral infarction and neurological deficits.
loading...
    loading...
Cat. No.: HY-12435
CAS No.: 1279867-21-8
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

SAR216471 is a P2Y12 receptor antagonist. SAR216471 reversibly blocks the binding of 2MeSADP to P2Y12 receptors in vitro with an IC50 of 17 nM. SAR216471 can result in the inhibition of platelet aggregation. SAR216471 exhibits anti-thrombotic activity in rat model. SAR216471 can be studied in research on thrombosis .
loading...
    loading...